See inside every stock. Pro
S&P 5007,663▼ 1.21%Nasdaq26,009▼ 2.60%Dow Jones52,868▲ 0.02%Nasdaq 10028,959▼ 2.90%VIX19.03▲ 14.09%US Dollar101.62▼ 0.16%Gold spot4,093▼ 0.80%WTI100.76▲ 1.30%
← RJF page
XStocksXray
Research report · 22 October 2026

Raymond James Financial Inc (RJF)

Financials · Investment Banking & Brokerage · US stock · price as of 22 Oct 2026

Key indicators

Price$159.19
52-week range$138.82 – $182.73
Market cap$31.4B
P/E (trailing)13.9×
Dividend yield1.4%
Revenue (last 12 months)$17.0B
Revenue growth (3y a year)12.1%
Price / book2.5×
Return on equity18.2%

Fair value

Fair value (average of valid models)$188.39 middle half of models $159 – $191
Versus priceUndervalued+18% to fair value
P/E multiple$159.59
P/B multiple$157.55
Dividend discount, stable$163.95
Dividend discount, multi-stage$272.47
Model uncertaintyMedium

X-Ray Score

55/ 100 · Low confidence · ahead of 62% of sector peers
Valuation61
Growth64
Profitability39
Financial health–
Dividends59

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

72.68104135167198Fair value $1882021-102023-012024-042025-072026-10

Executive summary

Raymond James Financial is a diversified financial services firm that provides wealth management, investment banking, trading, asset management and banking services. Financial advisors affiliated with its private client group manage investments for individuals, families and institutions. Its capital markets business advises and trades for companies and investors, while its asset management arm runs investment strategies and Raymond James Bank lends to clients and supports the group.

Revenue comes from advisory fees and commissions on client assets, investment banking and brokerage fees, asset management fees and interest income from the bank. Revenue was $17.0 billion over the last twelve months, with growth of 12.1% a year across the last three years. The site holds no operating margin or leverage figure for the company at present. It pays a dividend with a yield of 1.4%.

StocksXray gives Raymond James Financial Inc an X-Ray Score of 55 out of 100 (low confidence), ahead of 62% of the S&P 500 stocks in its sector. Its strongest lens is growth (64) and its weakest is profitability (39).

Our fair value (the average of the valid models) is $188.39 (range $159.08 to $191.08). At $159.19 the stock trades 15% below that value, so the label is "Undervalued" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Raymond James Financial Inc (RJF)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$85.84$93.19$96.30$118.75$169.69$159.19
Market cap$18.1B$20.1B$20.9B$25.2B$35.1B$31.4B
P/E12.9×13.4×12.1×12.2×16.5×13.9×
Price / book2.2×2.1×2.0×2.2×2.8×2.5×
Dividend yield1.21%1.46%1.74%1.52%1.18%1.36%

Fundamentals checklist ● 3 Good · ● 1 Average · ● 0 Bad · each check graded against the sector

Growth

EPS growth (3y)13.8%Average
Revenue growth (3y)12.1%Good
Growth consistency100%Good

Valuation

Fair value vs price1.2×Good
stocksxray.com · page 2
XStocksXray
Raymond James Financial Inc (RJF)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue9,91011,30812,99214,92315,91216,990
Net income1,4031,5091,7392,0682,1352,306
Diluted EPS ($)6.636.987.979.7010.3011.47
Net margin14.2%13.3%13.4%13.9%13.4%13.6%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets61,89180,95178,36082,99288,23094,237
Cash7,2016,1789,31310,99811,3899,977
Total debt81––––
Equity8,2459,45810,21411,67312,50312,699
Dividend per share ($)1.041.361.681.802.002.12

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%9%19%28%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)3,8453,8424,1904,1764,2624,362
Growth vs a year earlier+5.7%+2.1%+4.7%+3.5%+10.8%+13.5%
Net income ($M)495436604563544595
Diluted EPS ($)2.362.12–2.792.723.01
stocksxray.com · page 3
XStocksXray
Raymond James Financial Inc (RJF)

Peers in Investment Banking & Brokerage

CompanyX-Ray
RJF · Raymond James Financial In...55
SCHW · Schwab Charles Corp68
IBKR · Interactive Brokers Group,...51
GS · Goldman Sachs Group Inc49
HOOD · Robinhood Markets, Inc.45

Market Compass outlook for Financials: Favourable (71/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+1.2%
1 month+0.2%
3 months−4.9%
6 months+3.7%
1 year−2.8%
3 years+73.7%
5 years+66.9%

Technical summary

DailyBearish4 bullish · 4 neutral · 8 bearish
WeeklyNeutral5 bullish · 1 neutral · 6 bearish
MonthlyStrongly bullish6 bullish · 1 neutral · 1 bearish
50-day / 200-day average$166.63 / $159.43
52-week low / high$138.82 / $182.73
Classic pivot, support and resistanceS2 152.52 · S1 155.86 · P – · R1 160.91 · R2 162.62

Recent dividends

Ex-dividend dateAmount per share
1 Oct 2026$0.5400
1 Jul 2026$0.5400
1 Apr 2026$0.5400
2 Jan 2026$0.5400
1 Oct 2025$0.5000
1 Jul 2025$0.5000
stocksxray.com · page 4
XStocksXray
Raymond James Financial Inc (RJF)

Strengths

  • Revenue growth of 12.1% a year over three years is ahead of 76% of its sector peers.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

No check is weak against its sector.

Latest SEC filings

DateFormItems
23 Sep 20268-K7.01,9.01
1 Sep 20268-K5.02,7.01
19 Aug 20268-K7.01,9.01
5 Aug 202610-Q
22 Jul 20268-K2.02,9.01
24 Jun 20268-K7.01,9.01
27 May 20268-K7.01,9.01
20 May 20268-K7.01,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value is the average of up to 15 valuation models, most of them anchored to the company's own multiples, so it stays near the price and should be read as a range, not a point. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 23 Oct 2026